摘要
目的:观察血栓通联合奥扎格雷钠治疗急性脑梗死的临床疗效。方法:86例脑梗死患者随机分为治疗组和对照组各43例,两组患者均接受常规治疗,治疗组用奥扎格雷钠注射液80mg,血栓通注射液0.75,各加入液体中静脉点滴,每日1次。对照组用复方丹参注射液20ml,加入液体中静脉点滴,每日1次,均为15天为1疗程。结果:治疗组有效率明显优于对照组(P<0.01)。治疗后两组的神经功能缺损评分比治疗前明显降低(P<0.01),且治疗组下降更明显(P<0.05)。两组血液流变学检查各项指标均有改善,治疗组改善更明显,差异有统计学意义(P<0.01)。结论:血栓通联合奥扎格雷钠治疗急性脑梗死具有疗效明确、安全性高、不良反应少等优点。
Objective： Observed Ozagrel Xueshuantong combined clinical efficacy in treatment of acute cerebral infarction.Methods： 86 patients with cerebral infarction were randomly dMded into treatment group and control group 43 cases, two patients were treated with conventional therapy, the treatment group with Ozagrel injection 80mg, Xueshuantong injection of 0.75, each adding liquid intravenous drip, every Day 1. Control group, with compound Danshen injection 20ml adding intravenous fluids a day one time. are 15 days of a course of treatment.Results： The treatment group was significantly better than the control group（P〈0.01 ）, After treatment groups of nerve function deficit score significantly lower than before treatment（P〈0.01）, and the treatment group decreased more significantly（P〈0.05）. Blood examination two groups of indicators have improved, the treatment group improved more significantly, the difference was statistically significanl（P〈0,01）.Conclusion： Ozagrel Xueshuantong combined effect of the treatment of acute cerebral infarction with a clear, high security, the advantages of fewer adverse reactions.
出处
《中国医药导刊》
2009年第12期2075-2076,共2页
Chinese Journal of Medicinal Guide
关键词
血栓通
奥扎格雷纳
急性脑梗死
Xuesbuantong
ozagrel
acutc cerebralinfarction
